Today: 11 November 2025
Subscribe
Browse Category

Investment Opportunities News 8 October 2025 - 7 November 2025

Momentum (MMT) News Today — Nov 7, 2025: Bybit’s 400,000‑MMT Megadrop Live, Bitget Spot Listing This Week, OKX $1M Flash‑Earn Window Closes; Fresh Price Outlook

Momentum (MMT) News Today — Nov 7, 2025: Bybit’s 400,000‑MMT Megadrop Live, Bitget Spot Listing This Week, OKX $1M Flash‑Earn Window Closes; Fresh Price Outlook

This week’s context you should know Price & market snapshot (intraday) Public dashboards tracking MMT show heavy post‑listing volatility typical of early distribution phases. As of press time, third‑party aggregators indicate an active 24‑hour volume in the hundreds of millions (USD) and a price materially below the Nov 4 all‑time high (ATH) recorded after listings. Always check your exchange or a reliable aggregator before trading, as figures move fast. CryptoRank What to watch next: Bybit Megadrop & OKX Flash‑Earn — quick guides Bybit Megadrop (400,000 MMT):• Lock MNT or MMT and buy Earn products to earn points; your points determine
7 November 2025
 ·  ·  ·  · 
Is ALAR Stock the Next AI Goldmine? Discover Alarum’s Explosive Run and What Analysts Are Saying

Is ALAR Stock the Next AI Goldmine? Discover Alarum’s Explosive Run and What Analysts Are Saying

Stock Price Performance (as of Nov 4, 2025) Alarum Technologies (NYSE: ALAR) has rallied strongly in 2025. After closing around $16.25 on Nov 3 stockinvest.us, the stock is off its all-time high (~$18.00) but still stands well above its 2024 lows (~$5.45 marketbeat.com). In the last two weeks alone it has gained ~10.8% stockinvest.us. Year-to-date shares are up about +55% investing.com, driven by excitement over AI-related business. Volume has picked up on rising days, indicating positive investor interest stockinvest.us. Notably, the 50-day moving average is rising and has crossed above the 200-day average, a classic bullish signal stockinvest.us. Recent trading
4 November 2025
 ·  ·  ·  · 
Starting a Business in Ukraine in 2025: 10 Crucial Facts Every Entrepreneur Must Know

Ukraine’s 2025 Post-War Comeback: Booming Industries, Big Investments & Hidden Opportunities

Expert insights: As Concorde Capital’s Oleksandr Parashchiy cautions, even an end to fighting may initially trigger an economic “crisis” due to falling military spending, before reconstruction spending kicks in kyivindependent.com. Dragon Capital notes that if a ceasefire and partial refugee returns occur, GDP could jump to 5–7% in 2025 kyivindependent.com; but if the war drags on, around 3% growth is a more likely baseline kyivindependent.com. The IMF and EBRD stress that real recovery hinges on continued reforms: as one analysis summarizes, “economic recovery is as much about policy and investment climate as it is about money” ts2.tech. Ukraine’s leaders often
31 October 2025
 ·  ·  ·  · 
Crypto Market Explodes: Bitcoin Nears $115K as Hot Presale Tokens (BlockchainFX, Nexchain, Ozak AI) Promise 100x+ Gains

Crypto Market Explodes: Bitcoin Nears $115K as Hot Presale Tokens (BlockchainFX, Nexchain, Ozak AI) Promise 100x+ Gains

US–China Trade Deal Sparks Rally Equity and crypto markets are celebrating progress on a US–China trade truce. A Reuters roundup notes global stocks “jumped” on Oct.28 after reports of a framework deal on tariffs reuters.com. The S&P 500 hit a record high (+1%), while China’s CSI 300 and Japan’s Nikkei also rose reuters.com. Multi-asset strategist Evelyne Gomez-Liechti observed the familiar pattern – Trump threats followed by market relief once talks resume reuters.com. Ross Hutchison of Zurich Insurance adds: “There is scope for investors to buy into positive news flow here” reuters.com. Cryptocurrency has moved in sync. CoinDesk reported that “preliminary
29 October 2025
 ·  ·  ·  · 
Energy Stock on Fire: EPD’s 7% Yield and Massive Growth Plans Might Be About to Spark a Rally

Energy Stock on Fire: EPD’s 7% Yield and Massive Growth Plans Might Be About to Spark a Rally

Recent News & Industry Context The past week’s headlines have been upbeat for midstream energy. On Oct 7, EPD announced its Q3 distribution of $0.545/unit (payable Nov 14, record Oct 31) marketscreener.com – reinforcing a 27-year growth streak markets.financialcontent.com. Shortly after, a MarketBeat alert (Oct 25) noted that Weiss Ratings reaffirmed EPD at a “Buy” with an average $35.8 price target marketbeat.com. Insider buying news in late July (SEC filings) and reports of big institutional buys have also hinted at confidence. Broadly, pipeline and infrastructure stories dominated the energy news. Industry conferences (e.g. the Pennsylvania Shale Insight in early Oct) highlighted U.S. gas
25 October 2025
 ·  ·  ·  · 
Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

Market Reaction & Stock Performance D-Wave’s market performance has been nothing short of dramatic. After lingering near $1 in late 2024, QBTS exploded in 2025. By early October it had tripled on the year, and on Oct. 15 it briefly hit $46.75 – about a 30-fold jump from a year earlier ts2.tech ts2.tech. Technical indicators flagged the stock as “overbought” after that rally ts2.tech, and the subsequent selloff into Oct. 22 was swift: the stock fell about 35% from its high to close ~$27.30 on Oct. 22 ts2.tech ts2.tech. Traders cite profit-taking and a broad tech-sector wobble (fears of U.S.
24 October 2025
 ·  ·  ·  · 
SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi Stock Skyrockets 230% in 2025 as Earnings Loom – $1.6 Trillion Opportunity Sparks Frenzy

October Stock Surge After Volatile Weeks SoFi’s stock has been on a roller-coaster ride in recent weeks. After reaching an all-time high around $30.30 in late September amid fintech euphoria ts2.tech, the stock stumbled through early October – falling about 10–15% from its peak as investors locked in gains and broader market jitters hit high-growth tech shares. In fact, SoFi slid for seven straight sessions to mid-month, even tumbling 5% in one day on Oct. 16 to around $26.60 ts2.tech. “Most buyers are already in,” one analyst quipped during that pullback, suggesting the pool of new investors willing to chase the
22 October 2025
 ·  ·  ·  ·  · 
Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa’s stock story is a mix of bullish projects and market risks. The recent government-backed gallium plant (critical mineral for tech and defense) is a major positive, potentially diversifying Alcoa’s business beyond aluminium. Yet the industry is grappling with high US tariffs and costs. Below we break down these developments and what analysts are saying. Government support and the new Gallium project On Oct. 20, Alcoa announced that US and Australian agencies will provide funding for a joint venture to build a gallium plant at Alcoa’s Wagerup alumina refinery in Western Australia news.alcoa.com. In August Alcoa and a Japanese-US-Australian venture
21 October 2025
 ·  ·  ·  ·  · 
AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

CRDO’s Wild Ride on AI Hype Credo (NASDAQ: CRDO) has become one of 2025’s hottest AI infrastructure stocks. The company makes advanced cables and chips that connect GPUs inside AI supercomputers. In late September, Elon Musk’s xAI even showcased “thousands” of Credo’s bright purple cables in its new Colossus 2 data center rufinfeed.ru, underscoring the mystique around the firm’s products. Credo’s shares have soared over 1,300% since its 2022 IPO ts2.tech as the AI boom has made its AEC (active electrical cable) technology nearly indispensable: today Credo commands an ~88% share of the emerging multi-billion dollar AEC market rufinfeed.ru. This
19 October 2025
 ·  ·  ·  ·  · 
USA Rare Earth’s Meteoric Rise: The Pre-Revenue Mining Stock Targeting $30+ amid China Tensions

USA Rare Earth’s Meteoric Rise: The Pre-Revenue Mining Stock Targeting $30+ amid China Tensions

1. Company Overview: USAR’s Mine-to-Magnet Strategy USA Rare Earth, Inc. (Nasdaq: USAR) is a development-stage critical minerals company aimed at creating a fully domestic rare-earth supply chain. Its flagship asset is the Round Top Mountain deposit in West Texas (via a JV with Texas Mineral Resources) ts2.tech, a polymetallic site rich in light and heavy rare-earth elements (including dysprosium and terbium). USAR announced in early 2025 that it produced its first sample of 99%-plus dysprosium oxide from Round Top ore ts2.tech, demonstrating its ability to extract high-value heavy-REEs domestically. Downstream, USAR is building a neodymium-iron-boron (NdFeB) magnet factory in Stillwater,
13 October 2025
 ·  ·  ·  ·  · 
Protagonist Therapeutics (PTGX) Skyrockets on J&J Buyout Buzz Amid Clinical Breakthroughs

Protagonist Therapeutics (PTGX) Skyrockets on J&J Buyout Buzz Amid Clinical Breakthroughs

Recent News and Corporate Developments J&J Buyout Buzz: The biggest news propelling Protagonist’s stock is the report that Johnson & Johnson is in talks to acquire Protagonist reuters.com. On October 10, 2025, The Wall Street Journal broke the story (later confirmed by Reuters) that J&J is negotiating a purchase of Protagonist Therapeutics reuters.com. This potential acquisition would build on the companies’ ongoing partnership: J&J’s Janssen unit has held exclusive worldwide rights to develop and commercialize Protagonist’s peptide drug Icotrokinra (JNJ-2113) since a 2017 collaboration deal reuters.com. In fact, J&J already holds rights to market Icotrokinra and reportedly owns a ~4% stake in Protagonist, reflecting its early
10 October 2025
 ·  ·  ·  ·  · 
Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Why Intellia Therapeutics’ Stock Could Be a Gene‑Editing Goldmine in 2025 – Deep Dive into NTLA’s Prospects

Quick Facts (as of 8 Oct 2025) Recent Performance and News Phase 1 data fuels rally Intellia’s October rally was triggered by longer‑term Phase 1 results for nexiguran ziclumeran (nex‑z), an in‑vivo CRISPR therapy for transthyretin (ATTR) amyloidosis. A GlobeNewswire release (Sept 25 2025) reported that a single dose produced a rapid, deep and durable reduction of serum TTR levels—mean reduction 92 % at 24 months and 90 % at 36 months globenewswire.com. Patients also showed clinical improvements or stabilization of neuropathy and cardiac markers globenewswire.com, and safety findings were mostly mild infusion‑related events globenewswire.com. CEO John Leonard said the data “demonstrate rapid, deep and durable TTR reductions with meaningful clinical
8 October 2025
 ·  ·  ·  ·  · 
1 2
Go toTop